97. Ulcerative colitis Clinical trials / Disease details


Clinical trials : 2,527 Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03609905
(ClinicalTrials.gov)
July 1, 20181/6/2018Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative ColitisA Phase I/II Randomized, Controlled, Clinical Trial for Assessment of the Safety and Efficacy of Allogeneic Adipose Mesenchymal Stem Cells in Moderate to Severe Ulcerative Colitis PatientsUlcerative Colitis (UC)Biological: Adipose-cord mesenchymal stromal cells (A-MSCs);Other: Conventional drugsLiaocheng People's HospitalNULLRecruiting18 Years65 YearsAll50Phase 1/Phase 2China
2EUCTR2017-003524-75-NL
(EUCTR)
27/03/201819/02/2018Mesenchymal Stromal Cells for the treatment of Ulcerative ColitisAllogeneic Bone Marrow Derived Mesenchymal Stromal Cells for the Treatment of Refractory Proctitis in Ulcerative Colitis - BMMSCproctitis Ulcerative Colitis
MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Product Name: Mesenchymal stromal cells
Product Code: MSC
INN or Proposed INN: n.a.
Other descriptive name: MESENCHYMAL CELLS
Leiden University Medical CenterNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
14Phase 2Netherlands